This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy. Additionally, the bill revises the process by which the Department of Justice may modify the number of days within which such drugs must be administered.
To amend the Controlled Substances Act to lengthen the period of time 
 during which certain controlled substances must be administered to a 
   patient after being delivered by a pharmacy to the administering 
                             practitioner.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DELIVERY OF A CONTROLLED SUBSTANCE BY A PHARMACY TO AN 
              ADMINISTERING PRACTITIONER.

    Section 309A of the Controlled Substances Act (21 U.S.C. 829a) is 
amended--
            (1) in subsection (a)(5), by striking ``14 days'' and 
        inserting ``60 days''; and
            (2) in subsection (b)--
                    (A) by striking paragraph (1);
                    (B) by redesignating paragraphs (2) and (3) as 
                paragraphs (1) and (2), respectively;
                    (C) in paragraph (1), as so redesignated, by 
                striking ``the Attorney General,'' and all that follows 
                and inserting the following: ``the Attorney General may 
                modify the number of days described in subsection 
                (a)(5) if the Secretary determines that the 
                modification will--
                    ``(A) reduce the risk of diversion; or
                    ``(B) protect the public health.''; and
                    (D) in paragraph (2), as so redesignated, by 
                striking ``7 days'' and inserting ``14 days''.
                                 <all>
A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.
A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.
Official Titles - Senate
Official Title as Introduced
A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.
Sen. Shaheen, Jeanne